Applied Therapeutics, Inc. Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for patients with rare diseases. Based in Cambridge, England, it pursues drug programs intended to deliver transformative, life-changing outcomes for those with urgent medical needs. One program centers on govorestat (AT-007) for Sorbitol Dehydrogenase Deficiency, a form of Charcot-Marie-Tooth disease, with data presented from its INSPIRE Phase 2/3 study. In February 2026, Cycle Pharmaceuticals Limited completed the acquisition of Applied Therapeutics, after which Cycle assumed responsibility for the company’s operations. The organization is a small- to mid-sized player within the biotechnology research landscape, focused on advancing clinical-stage therapies for rare diseases.